TL;DR
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Neko Health says it plans to open a second Manhattan clinic at Brookfield Place in January and a Miami clinic by year-end, with San Francisco and Washington, D.C., also in its pipeline. The company says its U.S. waitlist has surpassed 50,000, but it has not released American rebooking figures or detailed dates for all planned sites.
Neko Health says it will add clinics in Manhattan and Miami after opening its first U.S. location in SoHo, expanding a paid preventive screening service whose U.S. waitlist has topped 50,000, according to the company. It also lists San Francisco and Washington, D.C., as locations in its pipeline, though dates for those sites have not been announced.
A second Manhattan clinic is scheduled to open at Brookfield Place in January, while the company expects its Miami location by the end of this year. The report does not specify exact opening days. Neko’s first U.S. clinic opened in SoHo the previous month. Before that opening, more than 25,000 New Yorkers had joined its waitlist; the company says the total more than doubled to over 50,000 in two weeks.
The company charges $499 for a scan. The noninvasive service combines skin imaging using visible light, infrared thermal imaging and depth sensing with blood pressure checks, an electrocardiogram and other cardiac measurements, body composition analysis, grip strength and eye pressure tests, and an on-site blood panel covering 53 biomarkers. A member reviews results with a clinician, and the visit takes about an hour, according to the report.
Neko says its cameras can flag moles for closer review and the scan focuses on cardiometabolic health and skin cancer. The company is explicit that the service is not an MRI or CT scan and does not image internal organs. It does not screen for breast, colon, lung or prostate cancer, among other cancers, and it cannot diagnose or rule out coronary artery disease. The company says follow-up referrals can go to partner providers or a customer’s own doctor.
A New Market for Paid Screening
The expansion tests whether consumers will pay directly for a bundled health assessment that combines testing, clinician review and a boutique clinic experience. At $499 per visit, Neko is positioning the service below some higher-priced longevity offerings, but it remains an out-of-pocket purchase for many customers. The company accepts HSA and FSA payments, which may allow eligible customers to use pre-tax funds set aside for health care.
The service is not a substitute for routine medical care or established cancer screening. Its stated limits matter: a scan that flags a possible concern still may require assessment by a clinician, and customers should continue recommended preventive care with their usual providers. Neko’s expansion adds to a growing group of businesses selling blood tests, imaging or other health services outside conventional clinic settings.
The company’s waitlist indicates interest, but it does not show how many people will ultimately book, complete or repeat a scan. The reported figure is a company-reported count, not evidence that the service improves health outcomes or is accessible to a broad share of the population.
Products Worth Considering
Oral-B iO Series 7 Rechargeable Electric Toothbrush with 2 Brush Heads and Charging Travel Case
Fitbit Versa Smart Watch – Black Aluminum, One Size (S & L Bands Included)
Withings Body Smart Wi-Fi and Bluetooth Body Composition Scale
As an affiliate, we earn on qualifying purchases.
From SoHo to Four Markets
Neko was co-founded by Spotify co-founder Daniel Ek and chief executive Hjalmar Nilsonne. Its U.S. launch follows operations in Sweden and the United Kingdom, where the company says more than 100,000 people have been scanned. Neko reports that 75% of members in those markets book and prepay for another scan before leaving, and 80% book a third after their second scan. Those figures are not U.S. results; the company has not shared equivalent rebooking data for American customers.
The expansion follows a $700 million Series C funding round led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, with participation from other investors, including Mark Zuckerberg, according to the report. Other businesses are also offering paid health assessments and testing. The report cites Life Time’s Miora clinics, wearable-linked blood testing and Fountain Life’s lower-priced Base membership as examples, but their services and pricing are not directly equivalent to Neko’s one-visit scan.
In comments reported when the SoHo clinic opened, Nilsonne described the company’s view that clearer health information can help people act on their health. That is the company’s stated rationale, not independent evidence that its screening service produces better health outcomes.
“What we’ve seen is unmistakable: when people can see their health clearly and know what to do about it, they get healthier.”
— Hjalmar Nilsonne, Neko Health co-founder and CEO
Opening Dates and U.S. Demand
The company has not given exact opening dates for Miami, San Francisco or Washington, D.C.; the report says Miami is due by year-end and identifies the other two cities only as being in the pipeline. It is also unclear how many people on the 50,000-plus waitlist have booked appointments, how long they may wait, or whether all planned clinics will open on the stated schedule.
Neko has not published U.S. repeat-booking figures, and the report does not provide independent evidence about the scan’s accuracy, follow-up outcomes or effects on health. The service’s stated scope is limited, and it does not screen for several major cancers or provide images of internal organs.
The Next Clinic Openings
The next stated milestones are the Miami clinic by year-end and the second Manhattan location at Brookfield Place in January. Neko has not supplied detailed schedules for either opening in the reported material. The company has also named San Francisco and Washington, D.C., as future markets without dates.
Further updates may clarify appointment availability, whether the openings proceed on schedule and how U.S. customers use the service after their first visit. Until the company releases those details, its waitlist and overseas repeat-booking figures should be kept separate from confirmed U.S. bookings or outcomes.
Key Questions
Where is Neko Health opening clinics?
The company says it plans a second Manhattan clinic at Brookfield Place and a Miami location. It has also named San Francisco and Washington, D.C., as cities in its pipeline.
When are the new clinics expected to open?
Miami is due by the end of the year, and Brookfield Place is scheduled for January, according to the report. Exact opening days and dates for San Francisco and Washington, D.C., have not been announced.
What does the $499 Neko scan include?
The company describes a noninvasive assessment including skin imaging, blood pressure and cardiac measurements, body composition, grip strength, eye pressure and a 53-biomarker blood panel, followed by a clinician review.
Does Neko’s scan screen for all cancers or replace medical care?
No. Neko says it does not screen for breast, colon, lung or prostate cancer, among other cancers, and does not image internal organs. It also says the scan cannot diagnose or rule out coronary artery disease. The company describes referrals for follow-up care, and the service should not be treated as a replacement for routine care or recommended screening.
Source: rss
